Palmatine improved fatty liver markers in a preclinical type 2 diabetes study Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats,...

A natural compound, palmatine, showed promise in easing fatty liver and inflammation in a preclinical diabetes study 🧬🩺
www.news-medical.net/news/2026032... #Palmatine #Type2Diabetes #FattyLiver